Hiroaki Shimokawa, MD, PhD
October 7th, 2013
A Novel Risk Score for Predicting MACE in Patients with Vasospastic Angina
Hiroaki Shimokawa, MD, PhD
Hiroaki Shimokawa discusses his research group’s JACC study, in which they developed a comprehensive clinical risk score for VSA patients.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?